Augmentin '125' and Keratitis - a phase IV clinical study of FDA data

Summary:

Keratitis is reported as a side effect among people who take Augmentin '125' (amoxicillin; clavulanate potassium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Acetaminophen, and have Productive cough.

The phase IV clinical study analyzes which people have Keratitis when taking Augmentin '125'. It is created by eHealthMe based on reports of 10,373 people who have side effects when taking Augmentin '125' from the FDA, and is updated regularly.

What is Augmentin '125'?

Augmentin '125' has active ingredients of amoxicillin; clavulanate potassium. It is often used in sinusitis. eHealthMe is studying from 10,452 Augmentin '125' users. Check the latest studies of Augmentin '125'.

What is Keratitis?

Keratitis (eye's cornea, the front part of the eye, becomes inflamed) is found to be associated with 418 drugs and 835 conditions by eHealthMe. Check the latest studies of Keratitis.

On Jul, 16, 2026

10,373 people reported to have side effects when taking Augmentin '125'.
Among them, 16 people (0.15%) have Keratitis.

Among these 16 people:

How long have people been on Augmentin '125' when they have Keratitis? *

What is the gender of people who have Keratitis when taking Augmentin '125'? *

female: 62.5 %
male: 37.5 %

What is the age of people who have Keratitis when taking Augmentin '125'? *

What are other drugs people take besides Augmentin '125'? *

What are other side effects people have besides Keratitis? *

Rashes (redness): 11 people, 68.75%
Erythema Multiforme (a type of hypersensitivity reaction): 11 people, 68.75%
Weakness: 9 people, 56.25%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 8 people, 50.00%
Indigestion: 8 people, 50.00%
Swallowing Difficulty: 8 people, 50.00%
Fever: 7 people, 43.75%
Nausea And Vomiting: 6 people, 37.50%
Rash Maculo-Papular (red area on the skin that is covered with small confluent bumps): 6 people, 37.50%
Lacrimal Disorder (disease of lacrimal duct): 6 people, 37.50%

What are the existing conditions these people have? *

Productive Cough: 5 people, 31.25%
Metastases To Bone (cancer spreads to bone): 4 people, 25.00%
Nausea (feeling of having an urge to vomit): 3 people, 18.75%
Nausea And Vomiting: 2 people, 12.50%
Spondyloarthropathy (any joint disease of the vertebral column): 1 person, 6.25%
Precocious Puberty: 1 person, 6.25%
Pneumonia Bacterial (pneumonia associated with bacterial infection): 1 person, 6.25%
Infection Parasitic: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Augmentin '125' and have Keratitis?

- Check whether Keratitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Augmentin '125':

Augmentin '125' (10,452 reports)

Keratitis treatments and more:

Keratitis (4,120 reports)

How severe was Keratitis and when was it recovered:

Keratitis in Augmentin '125'

Expand to all the drugs that have ingredients of amoxicillin; clavulanate potassium:

Keratitis and drugs with ingredients of amoxicillin; clavulanate potassium (35 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Augmentin '125':

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Keratitis:

Keratitis (418 drugs)

Browse all the conditions that are associated with Keratitis:

Keratitis (835 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on amoxicillin; clavulanate potassium (the active ingredients of Augmentin '125') and Augmentin '125' (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.